Eastern Bank Moderna, Inc. Transaction History

Eastern Bank

$2.4 Billion
Q2 2024

A detailed history of Eastern Bank transactions in Moderna, Inc. stock. As of the latest transaction made, Eastern Bank holds 14,244 shares of MRNA stock, worth $936,543. This represents 0.07% of its overall portfolio holdings.

Number of Shares

14,244

Previous 14,244 -0.0%

Holding current value

$936,543

Previous $1.52 Million 11.47%

% of portfolio

0.07%

Previous 0.07%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	BUY	$85.37 - $115.44 $4,268 - $5,772	50 Added 0.35%	14,244 $1.52 Million
Q4 2023 Jan 25, 2024	SELL	$69.51 - $104.43 $12,164 - $18,275	-175 Reduced 1.22%	14,194 $1.41 Million
Q2 2023 Jul 19, 2023	SELL	$118.5 - $160.53 $1.19 Million - $1.61 Million	-10,000 Reduced 41.04%	14,369 $1.75 Million
Q1 2023 Apr 19, 2023	SELL	$135.66 - $197.02 $1.29 Million - $1.87 Million	-9,475 Reduced 28.0%	24,369 $3.74 Million
Q4 2022 Jan 24, 2023	SELL	$118.38 - $210.04 $1.1 Million - $1.95 Million	-9,306 Reduced 21.57%	33,844 $0
Q3 2022 Oct 19, 2022	SELL	$118.07 - $194.18 $1.77 Million - $2.91 Million	-15,000 Reduced 25.8%	43,150 $5.1 Million
Q2 2022 Jul 20, 2022	SELL	$117.13 - $176.59 $2.05 Million - $3.09 Million	-17,500 Reduced 23.13%	58,150 $8.31 Million
Q1 2022 Apr 21, 2022	SELL	$126.46 - $235.05 $1.26 Million - $2.35 Million	-10,000 Reduced 11.68%	75,650 $13 Million
Q4 2021 Jan 26, 2022	SELL	$225.82 - $368.51 $2.82 Million - $4.61 Million	-12,500 Reduced 12.74%	85,650 $21.8 Million
Q3 2021 Oct 19, 2021	SELL	$221.9 - $484.47 $597,354 - $1.3 Million	-2,692 Reduced 2.67%	98,150 $37.8 Million
Q2 2021 Jul 20, 2021	BUY	$129.91 - $234.98 $13.1 Million - $23.7 Million	100,842 New	100,842 $23.7 Million

Others Institutions Holding MRNA

# of Institutions

1,113

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eastern Bank, based on Form 13F filings with the SEC.

News

Stay updated on Eastern Bank with notifications on news.

Account